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INTRODUCTION
Alcohol addiction is complex disorder characterized by high rates of relapse to alcohol seeking and alcohol taking behaviors. Given that relapse is a major obstacle in the treatment of alcohol addiction, attention has been focused on animal models to further our understanding of alcohol relapse and craving (Koob 2000; Spanagel 2003; Rodd et al. 2004a ).
There are animal models of drug-seeking that have elucidated the neural systems and mechanisms that underlie drug-seeking behavior. The cue-induced model provided evidence that EtOH-seeking behavior is associated with increased c-fos expression in the nucleus accumbens and medial prefrontal cortex (Dayas et al. 2007 ), whereas the stress-induced model of EtOHseeking behavior showed increased c-fos expression in the nucleus accumbens shell and core (Funk et al. 2006) . Taken together, the latter two studies suggest that neural substrates in the mesocorticolimbic system may be activated during EtOH-seeking behavior.
Pharmacological studies have provided further support that the dopamine (DA) system may play a role in EtOH-seeking behavior. Cue-induced EtOH seeking studies have shown that systemic administration of D 1 , D 2 , or D 3 receptor antagonists, or a D 3 partial agonist can dose dependently decrease EtOH-seeking behavior (Liu and Weiss 2002; Vengeliene et al. 2006 ).
Antagonism of the D 2 receptors in the nucleus accumbens reduced EtOH-seeking behavior in the appetitive/consummatory model (Samson and Chappell 2004) . Recent studies using the model of context-induced drug-seeking indicated that the D 1 receptors in the nucleus accumbens may also be involved in mediating EtOH-seeking behavior (Chaudhri et al. 2009 ).
The activation of DA neurons in the VTA has been indicated to be involved in mediating EtOH intake and the reinforcing properties of EtOH. For instance, the reduced activity of DA neurons in the VTA with a D 2 receptor agonist via local application or systemic administrations JPET # 168260 5 can reduce EtOH intake (Hodge et al. 1993; Nowak et al. 2000) . Intracranial self-administration studies, which elucidate specific neuroanatomical sites that support drug self-administration, have provided evidence that the VTA is also involved in the reinforcing effects of EtOH (Gatto et al. 1994; Rodd et al. 2004b, c) . Previous studies from our laboratory have shown that the posterior VTA (p-VTA), but not the anterior VTA (a-VTA), is a neuroanatomical site mediating the reinforcing actions of EtOH (Rodd-Henricks et al. 2000) . Moreover, the reinforcing effects of p-VTA require the activation of dopaminergic neurons (Rodd et al. 2004c; Rodd et al. 2005c ).
Spontaneous recovery is a learning phenomenon in which reintroduction to an environment previously paired with drug self-administration reinstates response-contingent behaviors for a previously obtainable reinforcer after extinction and a period of rest (Macintosh 1977) . Spontaneous recovery has been utilized to examine seeking behaviors for both cocaine and heroin, but the learning phenomenon has been coined the 'incubation model' (Grimm et al., 2001; Lu et al., 2009) . Pavlovian Spontaneous Recovery (PSR) is a unique phenomenon in that it is time dependent, and the behavior appears to be dependent on the re-exposure of the organism to all the cues in the behavioral environment previously associated with the reinforcer.
The expression of a PSR is directly correlated to reward saliency (Robbins 1990) , contextual cues associated with first-learned signals, and the amount of first-and second-learned associations (Brooks, 2000) . The PSR phenomenon has been asserted to be the result of an intrinsic shift away from the recent extinction (second-) learning to the initial reinforced learning responses, which reflects a motivation to obtain the previously administered reward (Bouton 2002 (Bouton , 2004 Rescorla 2001) . Therefore, the PSR model may represent a unique paradigm to study EtOH-seeking behaviors.
JPET # 168260
Research assessing EtOH-seeking behavior through the expression of PSR paradigm has been conducted in alcohol-preferring (P) rats (Rodd-Henricks et al. 2002a, b) . P rats will readily express a PSR (EtOH-seeking) for EtOH (Rodd-Henricks et al. 2002a, b; Rodd et al. 2006 ) and this expression of EtOH PSR can be enhanced by exposure to EtOH odor or EtOH priming (Rodd-Henricks et al. 2002a, b) .
The p-VTA is a neuroanatomical site mediating the reinforcing effects of EtOH and DA neuronal activity is involved (Rodd et al. 2000; Rodd et al. 2004 b, c; 2005c) . Sensitivity of the p-VTA to the reinforcing effects of EtOH increases with alcohol drinking and this enhanced sensitivity persists in the absence of alcohol for several weeks (Rodd et al. 2005a, b) . These latter results suggest that long-term neuroadaptations occurred in the p-VTA; these neuroadaptations may increase EtOH-seeking and contribute to vulnerability to relapse. The objective of the present study was to test the hypothesis that p-VTA is a neuroanatomical site mediating EtOHseeking behavior.
METHODS
Animals
Adult EtOH naïve female P rats from the 62nd generations weighing 250-325 g at the start of the experiment were used. Female rats were used in the present study because female rats maintain their body and head size better than male rats for more accurate and reliable stereotaxic placements. Previous research indicated that EtOH intake of female P rats was not affected by the estrus cycle (reviewed in McKinzie et al. 1998) . Rats were maintained on a 12-h reversed light dark cycle (lights off at 0900 h). Food and water were available in the home cage ad libitum throughout the experiment. All research protocols were approved by the institutional animal care and use committee and are in accordance with the guidelines of the Institutional Care and Use This article has not been copyedited and formatted. The final version may differ from this version. 
Chemical Agents and Vehicle
Ethyl alcohol (190 proof; McCormick Distilling Co., Weston, MO) was diluted to 15% with distilled water for operant oral self-administration sessions or diluted with artificial cerebrospinal fluid (aCSF) solution to 50 and 100 mg % EtOH for microinfusions. Quinpirole (Sigma, St. Louis, MO) was dissolved in the aCSF solution and the pH adjusted to 7.4 + 0.1 for microinjections. The aCSF consisted of: 120.0 mM NaCl, 4.8 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM Mg SO 4 , 25.0 mM NaHCO 3 , 2.5 mM CaCl 2 , and 10.0 mM D-glucose.
Operant Apparatus
EtOH self-administration procedures were conducted in standard two-lever experimental chambers (Coulbourn Instruments) contained within ventilated, sound-attenuated enclosures.
Two operant levers, located on the same wall, were 15 cm above a grid floor and 13 cm apart. A trough was directly beneath each lever, from which a dipper cup could raise to present fluid.
Upon a reinforced response on the respective lever, a small light cue was illuminated in the drinking trough and 4 seconds of dipper cup (0.1 ml) access was presented. A personal computer controlled all operant chamber functions while recording lever responses and dipper presentations.
Operant Training
Naïve P rats were placed into the operant chamber, without prior training. Operant sessions were 60 min in duration and occurred daily for 10 weeks (Rodd et al. 2006) . The EtOH concentration used for operant administration was 15% (vol/vol). During the initial 4 weeks of JPET # 168260 daily operant access, both solutions (water and EtOH) were reinforced on an FR-1 schedule. At the end of this time, the response requirement for EtOH was increased to an FR-3 schedule for 3 weeks, and then to FR-5 schedule for 3 weeks. After the P rats had established stable levels of responding on the FR5 schedule for EtOH and FR1 for water, they underwent 7 days of extinction (60 min/day), when neither water nor EtOH was available (Rodd et al. 2006 ). Water was not available during the extinction procedure since water is a primary reinforcer and has been shown to influence responding during extinction testing, i.e., superstitious behaviors (Macintosh 1977) . With the exception of no fluid being presented, the delivery system operated exactly as the preceding EtOH self-administration sessions.
Saccharin Operant Training
The operant procedure for saccharin (SACC) self-administration was similar to the EtOH procedure but 2 weeks shorter. Operant sessions were 60 min in duration and occurred daily for 8 weeks. The SACC concentration used for operant administration was 0.025% (g/vol). During the initial 4 weeks of daily operant access, both solutions (water and SACC) were reinforced on an FR-1 schedule. At the end of this time, the response requirement for SACC was increased to an FR-3 schedule for 3 weeks, and then to FR-5 schedule for 1 week.
Stereotaxic Surgeries
After extinction training, all rats were maintained in the home cages for 14 days. Previous research has shown that two weeks of home cage produce a robust PSR (Rodd -Henricks et al. 2002a, b; Rodd et al. 2006) . Stereotaxic implantation was performed after the animals had been in home cage for 7 days. While under isoflurane anesthesia, rats were prepared for bilateral stereotaxic implantation of 22-gauge guide cannula (Plastic One) into the p-VTA or a-VTA; the guide cannula was aimed 1.0 mm above the target region. Coordinates (Paxinos and Watson, JPET # 168260 1998) for placements to target the p-VTA were -5.6 mm posterior to bregma, + 2.1 mm lateral to the midline, and -8.5 mm ventral from the surface of the skull at a 10 o angle to the vertical.
Coordinates (Paxinos and Watson, 1998) for placements to target a-VTA were -4.8 mm posterior to bregma, + 2.1 mm lateral to the midline, and -8.5 mm ventral from the surface of the skull at a 10 o angle to the vertical. A 28-gauge stylet was placed into the guide cannula and extended 0.5 mm beyond the tip of the guide. After surgery, rats were individually housed and allowed to recover for 7 days in their home cage. Animals were handled for at least 5 min daily beginning on the fourth recovery day and were habituated for 2 consecutive days to the handling procedures necessary for microinjections.
For the SACC experiment, stereotaxic implantation into p-VTA was performed on the 1 st day of the 9 th week. On the day after surgery, rats were returned to the operant chambers. After 7 consecutive operant sessions post surgery, all rats were habituated to the handling procedures necessary for microinjections prior to placement in operant chambers.
Pavlovian Spontaneous Recovery (PSR) test
The PSR sessions were identical to the extinction protocol conditions. The FR5-FR1 schedule, lever contingencies and dipper functioning were maintained but EtOH and water were absent. Rats were given four consecutive PSR test sessions because previous studies have shown that adult P rats PSR start to return to baseline by the second session compared to periadolescence that show a more prolonged PSR (Rodd-Henricks et al. 2002a, b; Rodd et al. 2006 ).
Experiment 1: Microinjection of Quinpirole into the Posterior VTA
Rats (n=6-7/group) were microinjected bilaterally with vehicle (aCSF-control) or Quin (0.1 or 0.3 μg), as previously used by our lab (Nowak et al. 2000) . In addition, bilateral Although diffusion is a concern in all microinjection studies, previous studies using the current microinfusion technique demonstrated that Quin micro-injections 2 mm dorsal to the VTA did not change either EtOH or saccharin drinking behavior, which suggested that the actions of Quin were the result of activating receptors within the VTA and not due to diffusion along the outside of the guide cannula (Nowak et al. 2000) .
Experiment 2: Microinjection of EtOH into the Posterior VTA
Rats (n = 7-8/ group) were microinjected bilaterally with vehicle (aCSF) or EtOH (50 or 100 mg %). Doses of EtOH were selected based on previous research that shows P will selfadminister 50-200 mg % EtOH into the p-VTA (Gatto et al. 1994; Rodd et al. 2004b ). EtOH was administered using the electrolytic microinfusion transducer system (Rodd et al., 2004b) . This procedure was used to administer EtOH because this technique was successfully used in selfinfusion and microinjection experiments to determine behavioral and physiological responses of EtOH (Rodd et al. 2000; Rodd et al. 2004b, c; Ding et al. 2009 ). EtOH was administered consecutively to both sides of the p-VTA for 10 min/side using three 5-sec pulses/min; each 5-sec pulses infuses 100 nl. The microinjections were given prior to only the first 60 min PSR session starting approximately 20 min before the session.
The use of the electrolytic microinfusion transducer system has been shown to give relatively good neuroanatomical specificity. Previous studies with GABA A receptor antagonists or D 1 /D 2 receptor agonists (Ikemoto et al. 1997a,b) , cocaine (Rodd-Henricks et al. 2002a) , and
EtOH (Rodd-Henricks et al. 2000a ) demonstrated that diffusion away from the injection site did not appear to contribute to the reinforcing effects attributed to the target site.
Experiment 3: Microinjection of Quinpirole and EtOH into the Posterior VTA
Rats (n = 5-6/group) were microinjected bilaterally with Quin (0.01, 0.03, 0.1 or 0.3 μg)
following the same procedure as described in experiment one. Immediately following Quin infusion, rats were microinjected bilaterally with EtOH (100 mg %), using the same procedure as described in experiment two. The microinjections were given prior to only the first 60 min PSR session, starting approximately 20 min before the session.
Experiment 4: Microinjection of Quinpirole into the Anterior VTA
The same procedure for experiment 1 was used for the microinjections of Quin into the a-VTA. Rats (n = 7/group) were microinjected bilaterally with vehicle (aCSF-control) or Quin (0.1 or 0.3 μg). The microinjections were given prior to only the first 60 min PSR session, starting approximately 2 min before the session.
Experiment 5: Microinjection of EtOH into the Anterior VTA
The same procedure for experiment 2 was used for the microinjection of EtOH into the a-VTA. Rats (n = 7/group) were microinjected bilaterally with vehicle (aCSF) or EtOH (100 mg %). The microinjections were given prior to only the first 60 min PSR session starting approximately 20 min before the session.
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Responding During Maintenance
The same procedure for experiment 1 was used for the microinjections of Quin into the p-VTA. Rats (n = 5-7/group) were microinjected bilaterally with vehicle (aCSF-control) or Quin (0.3 μg). On the 11 th consecutive operant session post surgery, microinjections were given prior to only the first 60 min SACC maintenance test session, starting approximately 2 min before the session.
Histology
At the termination of the experiment, 1% bromophenol blue (0.5 μl) was injected into the infusion site. Subsequently, the animals were given a fatal dose of Nembutal and then decapitated. Brains were removed and immediately frozen at -70°C. Frozen brains were subsequently equilibrated at -15°C in a cryostat microtome and then sliced into 40-μm sections.
Sections then were stained with cresyl violet and examined under a light microscope for verification of the injection site using the rat brain atlas of Paxinos and Watson (1998).
Statistical Analysis
Overall operant responding (60 min) data were analyzed with a mixed factorial ANOVA with a between subject factor of dose and a repeated measure of 'session'. For the PSR experiments, the baseline measure for the factor of 'session' was the average number of responses on the EtOH lever for the last three extinction sessions. Post hoc Tukey's b was performed to determine individual differences. All analyses that were p < 0.05 was considered significant.
RESULTS
Histology Placements
The p-VTA is defined as the VTA region at the level of the interpeduncular nucleus at 5.3-6.3 mm posterior to bregma (Rodd-Henricks et al. 2000 ). In the current study, only animals that had correct injector placements were used in data analysis. As seen in Fig-1 , the a-VTA injector placements were at 4.8-5.2 mm posterior to bregma and the p-VTA injector placements were at 5.3-5.8 mm posterior to bregma. The success rate for correct a-VTA placements was 90% and for p-VTA placements the success rate was 80%. The incorrect injections sites were located in substantia nigra or red nucleus and these cannula placements that were found outside the VTA were excluded from analysis. Microinjections of EtOH into these areas did not have any effect on EtOH-seeking behavior, which is line with previous studies that show animals will not self-administer EtOH in these areas (Rodd-Henricks et al. 2000; Rodd et al. 2004 ).
Effects of Quinpirole Microinjection into the Posterior VTA on Responding in the PSR test.
Examining the number of responses on the lever previously associated with the delivery of EtOH (Fig-2A) In P rats treated with aCSF, there was a significant increase in responding on the EtOH lever during the initial PSR session compared to extinction baseline (p = 0.04). There was significant decrease in responding on the EtOH lever below extinction baseline levels in rats administered 0.1 or 0.3 µg Quin (p = 0.002). Responses on EtOH lever were very similar for all three groups during PSR sessions 2-4.
Baseline extinction responding on the lever previously associated with water was significantly higher in the aCSF group compared to extinction baseline values for the Quin groups (p =0.026). In addition, there was a significant decrease in water responding for the initial PSR session for the aCSF compared to extinction baseline values (Fig-2B ). The reduction that was observed for the aCSF group may due to the significantly higher extinction baseline for this group and may not be due to aCSF affecting water responding. There was a significant decrease in water responding for the initial PSR session for the 0.1 μg Quin groups compared to extinction baseline values (Fig-2B) however, there was no significant difference between extinction baseline and the initial PSR session for the higher dose Quin (0.3 μg ) group (p > 0.69).
Moreover, there were no significant differences on water lever responses between aCSF, 0.1 μg Quin, and 0.3 μg Quin groups during the initial PSR sessions (p values > 0.50). Responses on the water lever during sessions 2-4 were similar for all three groups.
Effects of Microinjecting EtOH into the Posterior VTA on Responding in the PSR test.
Examining the number of responses on the lever previously associated with the delivery of EtOH (Fig-3A) Responses on the EtOH lever during sessions 2-4 were similar for all three groups.
The analysis performed on the responses on the lever previously associated with the delivery of water indicated that responding on this lever was low (less than 15-30 responses per session) and did not differ from baseline ( p values >0.40) across PSR test sessions. There were also no differences between 'dose' groups during the initial PSR sessions (p values > 0.70).
Effects of Co-administration of Quin and EtOH into the Posterior VTA on Lever
Responses in the PSR test.
Examining the number of responses on the lever previously associated with the delivery of EtOH (Fig-4A) Compared to extinction baseline values, responding on the lever previously associated with water was significantly decreased during the initial PSR testing for rats administered 0.01
μg Quin with 100 mg % EtOH (p=0.038) and 0.1 μg Quin with 100 mg % EtOH (p = 0.018, see Fig-4B ). However, there were no significant differences on water lever responding for 0.03 μg Quin with 100 mg % EtOH (p = 0.053) and 0.3 μg Quin with 100 mg % EtOH (p = 0.407), see Fig-4B ). In addition, there were no significant differences between 'dose' groups during PSR session 1 (p values > 0.05).
Effects of Quinpirole Microinjection into the Anterior VTA on Responding in the PSR test.
Examining the number of responses on the lever previously associated with the delivery of EtOH (Fig-5A ) indicated a significant effect of 'session' (F 4, 15 = 54.8.11; p = 0.000).
However, the 'session' by 'dose' interaction was not significant (F 8, 28 = .289; p = 0.964).
Baseline level of responding was compared to responding during PSR testing within each group (t-tests).
In P rats treated with aCSF, 0.1 μg, and 0.3 μg of Quin , there was a significant increase in responding on the EtOH lever during the initial PSR session compared to extinction baseline (p = 0.006, p = 0.002, p = 0.019, respectively). There were no significant differences on EtOH responding between the aCSF, 0.1 μg, and 0.3 μg of Quin during the initial PSR test session.
Responses on the EtOH lever were also very similar for all three groups during PSR sessions 2-4.
Baseline extinction responding on the lever previously associated with water was not significantly different for any group (p > 0.26). In addition, there were no significant differences between 'dose' groups during the initial PSR sessions (p values = 0.24). Responses on the water lever during sessions 2-4 were similar for all three groups.
Effects of Microinjecting EtOH into the Anterior VTA on Responding in the PSR Test.
Examining the number of responses on the lever previously associated with the delivery of EtOH (Fig-6A ) indicated a significant effect of 'session' (F 4,9 = 6.595; p < 0.009). The 'session' by 'dose' interaction was not significant (F 4,9 = 1.226; p = 0.365). Baseline level of responding was compared to responding during PSR testing within each group (t-tests). In P rats treated with aCSF and 100 mg% EtOH, there was a significant increase in responding on the EtOH lever during the initial PSR session compared to extinction baseline (p = 0.014, p = .029, respectively). There were no significant differences on EtOH responding between the aCSF and 100 mg% EtOH during the initial PSR (p = 0.79). Responses on EtOH lever were also very similar for all three groups during PSR sessions 2-4.
Compared to extinction baseline values, responding on the lever previously associated with water was significantly decreased during the initial PSR testing for rats administered 100 mg % EtOH (p=0.025; see Fig-6B ). However, there were no significant differences between 'dose' groups during the initial PSR sessions (p values > 0.05).
Effects of Quinpirole Microinjection into the Posterior VTA on Saccharin Responding
During Maintenance.
As a control we examine the effects of Quin microinjected into the p-VTA on SACC responding. Examining the number of responses on the lever associated with the delivery of SACC (Fig-7) indicated that there was no significant effect of 'session' (F 5, 6 = 1.80; p = 0.251) and there was no significant 'session' by 'dose' interaction (F 5, 6 = 0.754; p = 0.613). Baseline level of responding was compared to responding during maintenance testing within each group (t-tests). In P rats treated with aCSF or 0.3 μg of Quin, there was no significant difference in responding on the SACC lever during the initial maintenance test session compared to baseline Baseline responding on the lever associated with water was not significantly different for any group compared to water lever responding during maintenance testing (p > 0.113, data not shown). The average number of responses on the water lever was < 15.
DISCUSSION
The major findings of this study are that local EtOH microinfusions into the p-VTA, and not the a-VTA, increased responding on the EtOH lever during the PSR test (Fig. 3A) , whereas local infusions of Quin into the same site reduced responding on the EtOH lever ( Fig. 2A) , suggesting that the p-VTA is a neuroanatomical site mediating EtOH-seeking behavior and that the activation of local DA neurons may be involved.
Electrophysiological studies have shown that local application of a D 2 receptor agonist can decrease firing rates of the VTA by activating D 2 cell body autoreceptors , whereas D 2 receptor antagonists will increase the firing rates of DA neurons in the VTA (Wang 1981; White and Wang 1984; Robertson et al. 1991) . In addition, local applications of a D 2 receptor agonist can reduce extracellular concentrations of DA in the VTA and the nucleus accumbens (Kalivas and Duffy 1991), whereas the infusion of a D 2 receptor antagonist into the VTA can enhanced the release of DA in the nucleus accumbens (Westerink et al. 1996) . The co-infusion of a D 2 receptor agonist with EtOH can prevent the acquisition and extinguish the maintenance of EtOH self-infusion into the p-VTA (Rodd et al. 2004c , Rodd et al. 2005c , whereas, sulpiride a D 2 receptor antagonist reinstated EtOH self-administration into p-VTA (Rodd et al. 2004c) . The
This article has not been copyedited and formatted. The final version may differ from this version. results of these studies, together with the present findings (Figs. 2 and 3) , suggest that VTA DA neuronal activity is needed for the expression of EtOH-seeking behavior.
In the present study, the PSR paradigm was used, which measures the relative strength of reinforcer-seeking behavior (i.e., possibly reflecting 'alcohol craving') to assess EtOH-seeking behavior. The present findings showed that microinfusion of Quin into the p-VTA can inhibit responding on the EtOH lever in the PSR test ( Fig. 2A) and also inhibit the local EtOHstimulated responding in the PSR test (Fig. 4A) . In contrast, microinfusion of Quin into the a-VTA did not have any effect on responding on the EtOH lever in the PSR test (Fig. 5A ). The doses of Quin administered in the current study were similar to doses used by Hodge et al. (1993) , who reported that even the highest dose of Quin (10μg/0.5μl) infused into the VTA did not impair motor activity. Previous research from our lab demonstrated that microinjections of 2-4μg of Quin into p-VTA or 2-6μg of Quin into a-VTA did not alter motor activity in female P rats (Nowak et al. 2000) . The results of the present study also indicated that Quin did not reduce motor activity when infused into the p-VTA or a-VTA because the highest dose of Quin did not alter responding on the water lever, and responses on the water lever following Quin infusions were similar to aCSF infusions (Fig. 2B, Fig 5B, respectively) . As a control we examine the effects of Quin on SACC maintenance. The results revealed that the highest dose of Quin (0.3 µg) did not alter responses on SACC lever (Fig. 7) . This is in line with Hodge et al., 1993, who reported that bilaterally microinjection of Quin as high 1.0 µg into the VTA did not significantly reduce sucrose self-administration. Collectively, these results indicate that Quin's effects in p-VTA on EtOH responding are not due to a non-specific inhibition on lever pressing.
The results of microinfusing EtOH alone into the p-VTA also provides support that the activation of local DA neurons are involved in mediating expression of EtOH-seeking behavior This article has not been copyedited and formatted. The final version may differ from this version.
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jpet.aspetjournals.org Downloaded from (Fig-3A) . There is evidence suggesting that EtOH can activate VTA DA neurons. Gessa et al. (1985) , using single cell recordings, demonstrated that EtOH can enhance the dopaminergic neurotransmission by increasing the firing rate of DA neurons in vivo. EtOH excitation of DA neurons was also observed in vitro for both extracellular and intracellular single unit studies in brain slices (Brodie et al. 1990; Brodie and Appel 1998) . Moreover, Brodie et al. (1999) provided evidence, using an acutely dissociated cell model, that the dopaminergic VTA neurons can be directly excited by EtOH. A recent study (Ding et al. 2009 ) indicated that direct microinjections of EtOH into the p-VTA increases DA release in the nucleus accumbens shell.
Overall, these results support the idea that EtOH can stimulate VTA DA neurons.
Compared to the vehicle group, a single micro-infusion of 50 or 100 mg % of EtOH significantly increased responding on the EtOH lever during the initial PSR session (1.6-and 2.0-fold higher, respectively). These results are in agreement with previous studies that demonstrated oral EtOH priming significantly enhanced responding on the EtOH lever compared to control responding in the PSR test (Rodd-Henricks et al. 2002a, b) . The EtOH concentrations administered in the present study were in range with previous EtOH self-infusions into the p-VTA (Gatto et al. 1994; Rodd et al. 2004b) . Similarly, blood EtOH levels attained under freechoice drinking conditions have been reported to be 50 to 200 mg% for P rats (Murphy et al. 1986 ). Therefore, the doses of EtOH used in the present study were within relevant pharmacological concentrations. Moreover, the enhanced EtOH responses did not appear to be a result solely of general locomotor activity because the animals were able to discriminate between the EtOH and the water levers. 2000; Rodd et al. 2004b; Rodd et al. 2004c; Rodd et al. 2005c) . The neuroadaptations that occur after chronic drinking and repeated alcohol deprivations seem to produce further increases in the reinforcing effects and the sensitivity of EtOH within the p-VTA (Rodd et al. 2005a, b) .
Furthermore, it is thought that drugs of abuse can prime responding by activating the mesolimbic DA system, which has become sensitized upon repeated drug use in a long lasting manner (Robinson and Berridge 1993) . Thus, our findings seem to suggest that local EtOH activation produces a priming effect in the p-VTA, but not the a-VTA, that promotes EtOH-seeking behavior (Fig-3A, Fig-6A ) by activating the DA neurons. It is noteworthy that studies have observed selective abnormalities in the P rats DA system projecting from the VTA to the nucleus accumbens (McBride et al. 1993 ) and increased VTA DA burst firing rates (Mozoratti 1998), suggesting that abnormalities underlying the high EtOH drinking behavior of the P line may reside within the VTA (Mozoratti 1998). Hence, further alterations of this system after chronic drinking and abstinence may also contribute to the enhancement of EtOH-seeking behavior observed in these animals.
Interestingly, there are several neuroanatomical differences between the p-VTA and a-VTA. For example, there are more DA neurons in the p-VTA than a-VTA projecting to the nucleus accumbens (Olson et al., 2005) , a higher proportion of DA to GABA neurons in the p-VTA than a-VTA (Olson et al., 2005) , and p-VTA has higher 5-HT innervations (Herve´ et al., 1987) . Lastly, the VTA containing DA neurons with topographical afferent and efferent projections may also differ between the anterior and posterior sites (Kalen et al., 1988; Brog et al., 1993; Tan et al., 1995) . Collectively, these studies provide evidence that DA activity may be greater in the p-VTA than in a-VTA.
This article has not been copyedited and formatted. The final version may differ from this version. In conclusion, these findings suggest that the p-VTA may be a neuroanatomical site mediating EtOH-seeking behavior in P rats and that activation of DA neurons is involved in this process. Therefore, the development of pharmacotherapeutics to reduce alcohol-craving should include a profile that regulates the activity of p-VTA DA neurons. with the delivery of water in P rats (n = 6-7/group) microinjected with aCSF, 0.1 μg or 0.3 μg/0.5 μl of Quin into the p-VTA prior to only the first PSR sessions. Asterisk (*) indicates that rats administered aCSF or 0.1 μg /0.5 μl of Quin responded significantly less on the water lever during the first PSR session compared to extinction baseline. There were no significant differences among the 3 groups with regard to responses on the water lever during PSR1. previously associated with the delivery of water in P rats (n = 7-8/group) microinjected with aCSF, or 50 or 100 mg % EtOH into the p-VTA prior to only the first PSR sessions. There were no significant differences. lever previously associated with the delivery of water in P rats (n = 7/group) microinjected with aCSF or 100 mg % EtOH into the a-VTA prior to only the first PSR sessions. There were no significant differences.
LEGENDS FOR FIGURES
Fig-7.
Mean (±S.E.M.) responses per session on the lever associated with the delivery of SACC in P rats (n = 5-7/group) microinjected with aCSF or 0.3 μg/0.5 μl of Quin into the p-VTA prior to only the first maintenance test session. There were no significant differences.
